Cleveland Research downgraded Bruker (BRKR) to Neutral from Buy.Stay Ahead of the Market: Discover outperforming stocks and invest smarter ...

Solution-state nuclear magnetic resonance (NMR) spectroscopy is the classical NMR spectroscopy approach used for molecular structure determination, where the experimental sample is studied while ...

The global nuclear magnetic resonance (NMR) spectroscopy market growth is driven by increasing investments in pharmaceutical research, chemical analy ...

Professor Steven Brown, director of the UK High-Field Solid-State NMR National Research Facility, said: “We are delighted to ...

At the ESCMID Global 2025 conference, Bruker Corporation’s BRKR Microbiology and Infection Diagnostics division has announced the expansion of its microbiology solutions into Next-Generation ...

Bruker Corporation BRKR has introduced an innovative Fourier 80 multinuclear benchtop FT-Nuclear Magnetic Resonance (NMR) spectrometer, known as the ‘Multi-Talent’ configuration. Unveiled at the Joint ...

Bruker Corporation BRKR has announced the successful development and testing of the world’s first high-resolution 1.3 GHz Nuclear Magnetic Resonance ("NMR") spectrometer at the Joint ENC-ISMAR ...

Bruker stock opened at $38.70 on Monday. The stock has a 50-day simple moving average of $48.29 and a 200-day simple moving average of $55.79. The company has a market capitalization of $5.87 ...

At the Joint ENC-ISMAR Conference 2025, Bruker Corporation, the leading provider of Nuclear Magnetic Resonance (NMR) spectroscopy solutions, announced the successful development and testing of the ...